Pedia-Lax sodium phosphate, dibasic and sodium phosphate, monobasic 3.5 g/66mL; 9.5 g/66mL Enema, 66 mL
by C.B. Fleet Company, Inc. · 66 mL in 1 BOTTLE, WITH APPLICATOR (0132-0202-20)
NDC 00132-0202-20
🏷️ FDA NDC (as labeled)
0132-0202-20
billing pads the labeler segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
0132-0202-20
Product NDC
0132-0202
11-digit billing NDC
00132020220
NCPDP billing unit
ML — per mL (volume)
RxCUI
283100
UNII
70WT22SF4B, 3980JIH2SW
Application #
M007
SPL Set ID
f001a37d-8ed4-428b-af12-d6a83c22c127
Established class (EPC)
Osmotic Laxative
Mechanism of action
Osmotic Activity
Physiologic effect
Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2002-05-10
Route
RECTAL
Dosage form
ENEMA
Substance
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC
GPI-14
46109902125110
GPI class
Fleet Pediatric
GCN Seq No
062501
GCN
98276
HICL code
001330
Ingredient (HICL)
Sodium Phosphate,Mono-Dibasic
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q3
Therapeutic class — intermediate (HIC2)
Anal-Rectal Preparations
HIC3 code
Q3S
Therapeutic class — specific (HIC3)
Laxatives, Local/Rectal
AHFS code
56:12.00.00
AHFS class
Cathartics And Laxatives
FDB label name
FLEET PEDIA-LAX ENEMA
FDB brand name
Pedia-Lax Enema
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0132-0202-20 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0202-20. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedMay 2002
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name FLEET PEDIA-LAX ENEMA Ingredient Sodium Phosphate,Mono-Dibasic
🧪 What is this product?
Pedia-Lax sodium phosphate enema is an over-the-counter rectal product containing two forms of sodium phosphate that work together as a laxative. These salts are typically used to draw water into the intestines to soften stool and promote bowel movements. This product is marketed under FDA's OTC monograph rules for laxative enemas and is intended for occasional use to relieve constipation.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about sodium phosphate, dibasic and sodium phosphate, monobasic?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII F5UM2KM3W7
Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
-
UNII 7FLD91C86K
Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesbenzalkonium chloride, disodium EDTA, purified water
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.021 | $1.35 / 66 ml |
| Medicaid paysCMS SDUD · 12 mo | $0.0432 | $2.85 / 66 ml |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
Flat over the last 6 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Saline Laxative 7 g/133mL; 19 g/133mL 00904-6320-78 | Major | 133 ml | $0.006 | — | Availability likely | save 69% |
| Foster and Thrive Ready to Use Saline Laxative 7 g/118mL; 19 g/118mL 70677-1089-01 | McKesson | 1 bottle | $0.006 | — | Availability likely | save 69% |
| Quality Choice Laxative 7 g/118mL; 19 g/118mL 83324-0292-45 | Chain | 1 bottle | $0.006 | — | Availability likely | save 69% |
| Quality Choice Laxative 7 g/118mL; 19 g/118mL 83324-0293-90 | Chain | 2 bottles | $0.006 | — | Availability likely | save 69% |
| Sunmark Saline Single Laxative 7 g/118mL; 19 g/118mL 49348-0186-14 | Strategic | 2 bottles | $0.007 | — | FDA listed | save 68% |
| HealthMart Saline Single Laxative 7 g/118mL; 19 g/118mL 62011-0271-01 | Strategic | 1 bottle | $0.008 | — | FDA listed | save 61% |
| Leader Ready to Use Saline Laxative 7 g/118mL; 19 g/118mL 70000-0108-01 | Cardinal | 1 bottle | $0.008 | — | FDA listed | save 61% |
| Fleet 7 g/118mL; 19 g/118mL 00132-0201-40 | C.B. | 133 ml | $0.010 | — | Availability likely | save 53% |
| Pedia-Lax 3.5 g/66mL; 9.5 g/66mLthis 00132-0202-20 | C.B. | 66 ml | $0.020 | — | Availability likely | — |
| Saline Laxative 7 g/118mL; 19 g/118mL 00363-0005-37 | Walgreen | 1 bottle | — | — | FDA listed | — |
| Equate Ready-to-Use Enema Laxative 7 g/118mL; 19 g/118mL 49035-0002-24 | WalMart | 6 bottles | — | — | FDA listed | — |
| Pure and Gentle Laxative 7 g/118mL; 19 g/118mL 53329-0014-11 | Medline | 1 bottle | — | — | FDA listed | — |
| Freds Saline Twin Pack Laxative 7 g/133mL; 19 g/133mL 55315-0301-01 | FRED'S | 2 bottles | — | — | FDA listed | — |
| Rexall Ready to use 4pk LAXATIVE 7 g/118mL; 19 g/118mL 55910-0999-06 | Dolgencorp, | 4 bottles | — | — | FDA listed | — |
| CVS Pharmacy 7 g/118mL; 19 g/118mL 59779-0959-11 | CVS | 1 bottle | — | — | FDA listed | — |
| NATUREPLEX Enema 19 g/133mL; 7 g/133mL 67234-0020-01 | Natureplex, | 1 bottle | — | — | FDA listed | — |
| Saline Enema 7 g/118mL; 19 g/118mL 67777-0402-02 | Dynarex | 1 bottle | — | — | FDA listed | — |
| Reflief Saline Laxative Pediatric Ready To Use 3.5 g/59mL; 9.5 g/59mL 69626-0085-07 | Leosons | 1 bottle | — | — | FDA listed | — |
| Quality Choice Single Saline Laxative 7 g/118mL; 19 g/118mL 71443-0001-06 | Alcyon | 6 bottles | — | — | FDA listed | — |
| Pro-Enema Single Saline Laxative 7 g/118mL; 19 g/118mL 71451-0001-01 | Propharma | 1 bottle | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2002
On the market since
May 2002
📍
2026
Currently FDA-listed
24 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00132-0202-20, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7.4K
Units reimbursed last 4 qtrs
2M
Gross reimbursed last 4 qtrs
$85.8K
Avg / prescription
$11.55
Avg / unit
$0.0432
Latest quarter Q4 2025
1.9KRx
Medicaid pays / mL
$0.0432
gross reimbursed
vs
NADAC / mL
$0.0205
acquisition cost
=
Spread
+$0.0227
+111% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 3,281 Rx Managed care · 4,145 Rx
State Medicaid map
Units reimbursed · per 100k residents
24.02,882
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pedia-Lax (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 42%
Female · 58%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00132-0202-20 You're viewing this | 66 mL in 1 BOTTLE, WITH APPLICATOR (0132-0202-20) | 2002-05-10 | Active |
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use for relief of occasional constipation.
⏱️ Dosage and Administration ▾
Directions Single Daily Dosage (per 24 hours) Do not use more per day unless directed by a doctor. See Warnings . Do not use if child is taking another sodium phosphates product.
Age Dose children 5 to 11 years 1 bottle per day or as directed by doctor children 2 to under 5 years one-half bottle per day (see below) children under 2 years DO NOT USE One-half bottle preparation: Unscrew cap and remove 2 tablesppons of liquid with a measuring spoon. Replace cap and follow “How to use this enema” directions.
⚠️ Warnings ▾
Warnings For rectal use only. Dosage Warning: Using more than one enema in 24 hours can be harmful. Do not use without asking a doctor: for more than 3 days if your child has a kidney disease if your child has heart problems if your child is dehydrated Ask a doctor before using this product if the child is on a sodium-restricted diet Ask a doctor before using any laxative if your child has abdominal pain, nausea, or vomiting a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week Stop use and ask a doctor if your child has rectal bleeding no bowel movement or no liquid comes out of the child’s rectum after 30 minutes symptoms of dehydration [feeling thirsty, dizziness, vomiting, urinating less often than normal] These symptoms may indicate a serious condition.
Keep out of reach of children to prevent accidental ingestion. If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active Ingredients (in each 59-mL delivered dose) Monobasic Sodium Phosphate 9.5 g................ Dibasic Sodium Phosphate 3.5 g........................
🧪 Inactive Ingredients ▾
Inactive Ingredients benzalkonium chloride, disodium EDTA, purified water
🎯 Purpose ▾
Purpose Saline laxative Saline laxative
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.